KLTO - Klotho Neurosciences Inc.
0.166
-0.014 -8.434%
Share volume: 230,716
Last Updated: 05-07-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.02%
PREVIOUS CLOSE
CHG
CHG%
$0.18
-0.01
-0.08%
View ratios
Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
---|---|---|---|---|
Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | |
Report Date | 05-23-2024 | 08-19-2024 | 11-19-2024 | |
Total revenue | 0.000 | 0.000 | 0.000 | |
Cost of revenue | 0.000 | 0.000 | 0.000 | |
Gross profit | 0.000 | 0.000 | 0.000 | |
nan% | nan% | |||
Operating expenses | 324.777 K | 395.607 K | 2.871 M | |
Selling general and admin | 324.777 K | 395.607 K | 2.871 M | |
Research and development | 0.000 | 0.000 | 0.000 | |
Total expenses | 342.777 K | 395.607 K | 2.871 M | |
15.41% | 625.70% | |||
Operating income | -342.777 K | -395.607 K | -2.871 M | |
Ebit | -325.817 K | -436.575 K | -2.914 M | |
Pretax income | -74.154 K | -451.639 K | -2.959 M | |
509.06% | 555.26% | |||
Income tax | 49.069 K | 0.000 | 0.000 | |
Net income basic | 0.000 | 0.000 | 0.000 | |
Net income | -123.223 K | -451.639 K | -2.959 M | |
-266.52% | -555.26% |